Grifols SA (GRFS)
9.545
+0.48
(+5.24%)
USD |
NASDAQ |
Nov 14, 16:00
9.545
0.00 (0.00%)
After-Hours: 20:00
Grifols Profit Margin (Quarterly): 2.88% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.88% |
| June 30, 2024 | 0.82% |
| December 31, 2023 | 4.16% |
| September 30, 2023 | 3.73% |
| June 30, 2023 | 2.29% |
| December 31, 2022 | 1.17% |
| September 30, 2022 | 2.89% |
| June 30, 2022 | 5.86% |
| June 30, 2021 | 10.13% |
| March 31, 2021 | 10.97% |
| December 31, 2020 | 10.15% |
| September 30, 2020 | 19.76% |
| June 30, 2020 | 2.30% |
| March 31, 2020 | 14.41% |
| December 31, 2019 | 14.82% |
| September 30, 2019 | 10.39% |
| June 30, 2019 | 13.62% |
| March 31, 2019 | 9.89% |
| December 31, 2018 | 10.50% |
| September 30, 2018 | 13.05% |
| June 30, 2018 | 16.00% |
| March 31, 2018 | 14.02% |
| December 31, 2017 | 21.63% |
| September 30, 2017 | 14.55% |
| June 30, 2017 | 12.72% |
| Date | Value |
|---|---|
| March 31, 2017 | 12.62% |
| December 31, 2016 | 12.69% |
| September 30, 2016 | 14.16% |
| June 30, 2016 | 14.02% |
| March 31, 2016 | 13.06% |
| December 31, 2015 | 12.28% |
| September 30, 2015 | 14.43% |
| June 30, 2015 | 13.41% |
| March 31, 2015 | 14.14% |
| December 31, 2014 | 14.31% |
| September 30, 2014 | 13.80% |
| June 30, 2014 | 12.78% |
| March 31, 2014 | 15.16% |
| December 31, 2013 | 11.29% |
| September 30, 2013 | 12.65% |
| June 30, 2013 | 13.17% |
| March 31, 2013 | 13.31% |
| December 31, 2012 | 8.97% |
| September 30, 2012 | 9.93% |
| June 30, 2012 | 10.15% |
| March 31, 2012 | 10.13% |
| December 31, 2011 | 1.10% |
| September 30, 2011 | 4.30% |
| June 30, 2011 | -3.84% |
| March 31, 2011 | 12.87% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
0.82%
Minimum
Jun 2024
19.76%
Maximum
Sep 2020
7.09%
Average
4.16%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| Cellectis SA | -142.3% |
| Adaptimmune Therapeutics PLC | 54.22% |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | -- |
| Verona Pharma PLC | -763.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.43% |
| Return on Assets | 0.93% |
| Return on Invested Capital | 1.23% |
| Gross Profit Margin (Quarterly) | 40.53% |
| Operating Margin (Quarterly) | 17.82% |
| Return on Net Operating Assets | 1.06% |